|
CHCHD7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.659600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.572000E-02 |
| Normal-vs-Stage2 |
7.566000E-02 |
| Normal-vs-Stage3 |
5.791900E-02 |
| Normal-vs-Stage4 |
5.798400E-04 |
| Stage1-vs-Stage2 |
5.001800E-01 |
| Stage1-vs-Stage3 |
7.495400E-01 |
| Stage1-vs-Stage4 |
5.468100E-02 |
| Stage2-vs-Stage3 |
6.978800E-01 |
| Stage2-vs-Stage4 |
3.534400E-01 |
| Stage3-vs-Stage4 |
1.256590E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.158900E-03 |
| Normal-vs-AfricanAmerican |
3.277700E-02 |
| Normal-vs-Asian |
8.140600E-01 |
| Caucasian-vs-AfricanAmerican |
4.291800E-01 |
| Caucasian-vs-Asian |
1.575540E-02 |
| AfricanAmerican-vs-Asian |
2.121500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.435730E-02 |
| Normal-vs-Female |
1.676380E-02 |
| Male-vs-Female |
6.151600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.346630E-01 |
| Normal-vs-Age(41-60Yrs) |
5.616500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.792300E-04 |
| Normal-vs-Age(81-100Yrs) |
8.539200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.524400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.192120E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.065400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.778100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.469400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.111780E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.703000E-01 |
| Classical-VS-Follicular |
1.395800E-03 |
| Classical-VS-Other |
6.987800E-01 |
| Classical-VS-Normal |
3.143200E-01 |
| Tall-VS-Follicular |
1.585350E-01 |
| Tall-VS-Other |
8.585200E-01 |
| Tall-VS-Normal |
6.960400E-02 |
| Follicular-VS-Other |
4.723400E-01 |
| Follicular-VS-Normal |
6.350700E-04 |
| Other-VS-Normal |
4.073000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.397200E-03 |
| Normal-vs-N1 |
1.475830E-03 |
| N0-vs-N1 |
2.391400E-01 |
|
|
